JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB193473

Recombinant Hepatitis B virus Hepatitis B Surface Antigen AD protein

Recombinant Hepatitis B virus Hepatitis B Surface Antigen AD protein

Be the first to review this product! Submit a review

|

(3 Publications)

Recombinant Hepatitis B virus Hepatitis B Surface Antigen AD (HBsAg) protein is a Full Length protein, expressed in Saccharomyces cerevisiae, with >95% purity and suitable for western blot, SDS-PAGE and ELISA.The predicted molecular weight of ab193473 protein is 24 kDa.

- Corresponds to short form HBsAg (S-HBsAg)
- Save time and ensure accurate results- use our HBsAg protein as a control

別名を表示する

S gene subtype adw2, sAg, ssAg

Key facts

精製度

>95% SDS-PAGE

Recombinant Hepatitis B surface antigen AD expressed in Saccharomyces cerevisiae and purified via ionic exchange chromatography, size exclusion chromatography and sterile filtration.

発現系

Saccharomyces cerevisiae

タグ

Tag free

アプリケーション

WB, ELISA, SDS-PAGE

applications

生物活性

No

アニマルフリー

No

キャリアフリー

No

バッファー組成

Preservative: 0.09% Sodium azide Constituents: PBS

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

製品の詳細

Ensure the validity of your result using our Recombinant Hepatitis B Surface Antigen AD protein ab193473 as a positive control in western blot and SDS-PAGE.

Analyze your HBsAg ELISA data using the ab193473 protein to generate and plot a standard curve.

Check out of western blot protocol for more information here

Check out our protein gel staining guide for SDS-PAGE here

Check out our ELISA protocol for more information here.

配列情報

[{"linker":null,"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"24 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":null,"accessionNumber":null,"tags":[]}]

出荷温度及び保存条件

製品の状態
Liquid
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
+4°C
保管に関する情報
Do Not Freeze
False

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The Hepatitis B Surface Antigen AD also known as HBsAg protein or HBV protein is an important component of the hepatitis B virus (HBV). This protein forms a structural element of the viral envelope with an approximate mass of 24 kilodaltons. It is expressed on the surface of infected hepatocytes which are liver cells. HBsAg contributes to the virus's ability to attach to and enter cells playing an essential role in the viral infective cycle. The Hep B recombinant protein produced in labs assists in studying this mechanism.
Biological function summary

The HBsAg protein plays a critical role in immune evasion. It forms part of non-infectious virus-like particles in the bloodstream which can reach high concentrations. These particles help the virus avoid the host's immune response complicating the clearance of infection. HBsAg is not part of a complex but acts independently to bind to receptors on host cells facilitating viral entry and subsequent replication of HBV proteins. Its function in immune modulation highlights its importance beyond mere structural roles.

Pathways

The HBsAg protein is heavily involved in the viral replication and infection pathways of HBV. It interacts with the hepatocyte sodium taurocholate cotransporting polypeptide (NTCP) a receptor critical for HBV entry into liver cells. This protein assists in establishing persistent infection. Moreover HBsAg influences the host's immune signaling pathways including the inhibition of pathways that lead to interferon production critical for antiviral responses. The protein balances viral replication with evasion of the immune system.

The Hepatitis B Surface Antigen AD links directly to hepatitis B infection and its chronic liver consequences. Hepatitis B can progress to serious conditions like liver cirrhosis and hepatocellular carcinoma if untreated. HBsAg remains a major marker for active infection and a vaccine target to prevent disease progression. The presence of this protein indicates viral replication and its persistence in the bloodstream is associated with chronic hepatitis B infection. Additionally HBsAg's relationship with proteins like HBx which is involved in the development of liver cancer illustrates its role in disease pathogenesis.

一般的な情報

製品プロトコール

文献 (3)

Recent publications for all applications. Explore the full list and refine your search

Mikrochimica acta 191:669 PubMed39400624

2024

Bioreceptors' immobilization by hydrogen bonding interactions and differential pulse voltammetry for completely label-free electrochemical biosensors.

Applications

Unspecified application

Species

Unspecified reactive species

Adaris López-Marzo,Marta Mas-Torrent

Microsystems & nanoengineering 9:137 PubMed37937185

2023

C-MEMS-derived glassy carbon electrochemical biosensors for rapid detection of SARS-CoV-2 spike protein.

Applications

Unspecified application

Species

Unspecified reactive species

Naresh Mandal,Raja Mitra,Bidhan Pramanick

Cell reports 38:110217 PubMed35021101

2022

Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens.

Applications

Unspecified application

Species

Unspecified reactive species

Benjamin J Read,Lori Won,John C Kraft,Isaac Sappington,Aereas Aung,Shengwei Wu,Julia Bals,Chengbo Chen,Kelly K Lee,Daniel Lingwood,Neil P King,Darrell J Irvine
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com